Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application

Real-Time Quote  
Real-Time Quote Not Available Why not?
Real-Time Quote Only available during pre-market and regular market hours. about
  • Day Low  3.75 02:11 PM EST  
    Day High 3.85 09:32 AM EST
    Range 0.10  
    Volume 790,852  
    30-Day Avg Vol 1.16 M
    Difference -32.00%  
    Market Cap 296.05 M  
    Mkt Cap Chg 783,214  
    Shares Out 78.32 M  
    % Shrs Traded 1.01%  
    1yr EPS Est 0.62  
    52-Wk Low 3.29
    52-Wk High 7.66
    Range 4.37  
    Prev Close 3.77 11/20/09  
    Today's Open 3.84  
    Change 1.86%
    Dividend (TTM)  
    Div Yield (TTM)
    Ex-Div Date
    Div Date
    Short Interest 11.57 M

    Performance Details

    Revenue (LFY) 110.18 M  
    Earnings (LFY) 29.20 M  
    Earnings (MRQ) 11.94 M  
    Next Earn Est 0.17  
    Next Earnings 03/08/2010
    EPS (TTM) 0.56  
    1yr EPS Growth -6.06%  
    P/E Ratio (TTM) 7.56  
    P/E Ratio (Fwd) 6.10  
    PEG Ratio 0.87  
    Return on Equity 23.02  
    Beta 1.74  
    Sector Healthcare  
    Industry Drugs  
    Click icons above for more info
  • Set and Manage Alerts

    Alert me if
  • Blog Posts: AOB

    Blogs are not currently available for aob.

    View all blogs at BloggingStocks.

  • Related Information: AOB

    Company Overview: AOB

    American Oriental Bioengineering (AOBO) is firmly planted in the pharmaceutical industry. Through subsidiaries, AOBO makes more than 20 plant-based pharmaceuticals and nutraceuticals based on Traditional ... View Full Description

    Earnings Analysis: AOB

    Analyst Consensus

    • Strong Buy
    • Buy
    • Hold
    • Sell
    • Strong Sell
    Earnings/Share(EPS) Estimate Actual Difference
    Next Quarter 0.17 3/8/10
    Last Quarter 0.17 9/30/09 0.13 9/30/09 -0.04
    Missed
    2 Quarters Ago 0.176 6/30/09 0.17 6/30/09 -0.006
    Missed

    Financials: AOB

      Quarterly - 09/30/2007 Annual - 2006
    Total Revenue 43.51 M 110.18 M
    Gross Profit 30.30 M 68.51 M
    Operating Income 13.98 M 36.38 M
    Net Income 11.94 M 29.20 M